Satoshi Morita

40.8k citations
764 papers · 18.6k · 5 hit papers · h-index 65

Impact in

    • Lung Cancer Treatments and Mutations
    • Gastric Cancer Management and Outcomes
    • Lung Cancer Diagnosis and Treatment
  • Oncology top 0.2%
    • Colorectal Cancer Treatments and Studies
    • Pancreatic and Hepatic Oncology Research
    • Lung Cancer Research Studies

Papers in

    • Gastric Cancer Management and Outcomes 109
    • Lung Cancer Treatments and Mutations 94
    • Lung Cancer Diagnosis and Treatment 35
    • Colorectal Cancer Treatments and Studies 94
    • Cancer Treatment and Pharmacology 58
    • HER2/EGFR in Cancer Research 35

Satoshi Morita

735 papers receiving 18.2k citations

Satoshi Morita's Hit Papers

Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non–Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study 2019 · 360 citations
3600+5+11Years since publication100200300400500

Peers

Satoshi Morita
Comparison fields: 5 of 184
  • Pulmonary and Respiratory Medicine 6.2k
  • Oncology 5.0k
  • Gastroenterology 676
  • Hepatology 917
  • Hematology 811
Replace Valter Torri with:
Valter Torri Italy
John J. Crowley United States
Anna E. Barón United States
Laurence H. Baker United States
Jørgen H. Olsen Denmark
Julia Brown United Kingdom
Gregory R. Pond Canada
Barry A. Siegel United States
Mark Krailo United States
Chul Ahn United States
Satoshi Morita relative to Valter Torri Italy Valter Torri's profile →
Citations per field
00.5×2.8×
Valter Torri · 1×
Citations per year

Countries citing papers authored by Satoshi Morita

Since Specialization
Citations

This map shows the geographic impact of Satoshi Morita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Morita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Morita more than expected).

Fields of papers citing papers by Satoshi Morita

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Morita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Morita. The network helps show where Satoshi Morita may publish in the future.

Co-authors

The 25 scholars most cited alongside Satoshi Morita, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Satoshi Morita Line = papers co-authored together Satoshi Morita links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 764 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Human iPS cell-derived dopaminergic neurons function in a primate Parkinson’s disease model
Hit paper breakdown →
2017531
2
Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)
Hit paper breakdown →
2012431
3
First-Line Gefitinib for Patients With Advanced Non–Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Without Indication for Chemotherapy
Hit paper breakdown →
2009380
4
Randomized, Open-Label, Phase III Study Comparing Irinotecan With Paclitaxel in Patients With Advanced Gastric Cancer Without Severe Peritoneal Metastasis After Failure of Prior Combination Chemotherapy Using Fluoropyrimidine Plus Platinum: WJOG 4007 Trial
Hit paper breakdown →
2013363
5
Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non–Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study
Hit paper breakdown →
2019360
6 2000315
7 2010252
8 2013247
9 2013195
10 2010173
11 2017166
12 2009157
13 2009157
14 2009153
15 2011149
16 2017143
17 2010140
18 2017139
19 2013134
20 2009133

About Satoshi Morita

Satoshi Morita is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Cancer Research, having authored 764 papers that have together received 18.6k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (109 papers), Colorectal Cancer Treatments and Studies (94 papers), Lung Cancer Treatments and Mutations (94 papers), Cancer Treatment and Pharmacology (58 papers), HER2/EGFR in Cancer Research (35 papers), Lung Cancer Diagnosis and Treatment (35 papers), Statistical Methods in Clinical Trials (28 papers) and Hepatocellular Carcinoma Treatment and Prognosis (26 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (6.2k citations), Oncology (5.0k citations), Gastroenterology (676 citations), Hepatology (917 citations) and Hematology (811 citations). Satoshi Morita has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Masataka Taguri, Junichi Sakamoto, Yasuhiro Kodera, Akira Inoue, Masami Okamoto, Tadao Kotaka, Kunihiko Kobayashi, Koichi Hagiwara, Akihiko Gemma and Isamu Okamoto. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Japanese Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology and International Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact